The Efficacy and Cost-Effectiveness of Umeclidinium/Vilanterol versus Tiotropium in Symptomatic Patients with Chronic Obstructive Pulmonary Disease

Figure 5

Forest plot of severe adverse event results for UMEC/VI vs. TIO using random-effects meta-analysis.